Ishita Drugs and Industries Limited reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was INR 44.96 million compared to INR 26.27 million a year ago. Revenue was INR 46 million compared to INR 27.15 million a year ago. Net income was INR 2.82 million compared to INR 1.79 million a year ago. Basic earnings per share from continuing operations was INR 0.94 compared to INR 0.6 a year ago. Diluted earnings per share from continuing operations was INR 0.94 compared to INR 0.6 a year ago. Basic earnings per share was INR 0.94 compared to INR 0.6 a year ago. Diluted earnings per share was INR 0.94 compared to INR 0.6 a year ago.
For the full year, sales was INR 151.88 million compared to INR 120.72 million a year ago. Revenue was INR 154.68 million compared to INR 122.73 million a year ago. Net income was INR 7.49 million compared to INR 5.77 million a year ago. Basic earnings per share from continuing operations was INR 2.5 compared to INR 1.93 a year ago. Diluted earnings per share from continuing operations was INR 2.5 compared to INR 1.93 a year ago. Basic earnings per share was INR 2.5 compared to INR 1.93 a year ago. Diluted earnings per share was INR 2.5 compared to INR 1.93 a year ago.